Passage Bio Stock Performance
| PASG Stock | USD 11.50 0.77 7.18% |
Passage Bio holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 5.21, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Passage Bio will likely underperform. Use Passage Bio expected short fall, and the relationship between the value at risk and daily balance of power , to analyze future returns on Passage Bio.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Passage Bio are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Passage Bio reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 7.18 | Five Day Return (8.00) | Year To Date Return (1.63) | Ten Year Return (97.41) | All Time Return (97.41) |
Last Split Factor 1:20 | Last Split Date 2025-07-14 |
1 | How Passage Bio Inc. stock reacts to Fed rate cuts - 2025 Analyst Calls Low Volatility Stock Suggestions - newser.com | 11/04/2025 |
2 | Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights | 11/10/2025 |
3 | How Passage Bio Inc. stock reacts to Fed rate cuts - Portfolio Profit Report Precise Swing Trade Alerts - newser.com | 11/13/2025 |
4 | Passage Bio versus PepGen Financial Contrast | 12/04/2025 |
5 | Will Passage Bio Inc. stock benefit from green energy trends - July 2025 Review Stepwise Trade Signal Guides - DonanmHaber | 12/19/2025 |
6 | Passage Bio, Inc. Given Consensus Rating of Moderate Buy by Analysts | 12/24/2025 |
7 | Disposition of 5000 shares by Kathleen Borthwick of Passage Bio subject to Rule 16b-3 | 01/08/2026 |
8 | Moving Averages What is the earnings history of Passage Bio Inc - Market Trend Review Short-Term Trading Opportunity Alerts - baoquankhu1.vn | 01/22/2026 |
| Begin Period Cash Flow | 21.7 M | |
| Total Cashflows From Investing Activities | 54.9 M |
Passage Bio Relative Risk vs. Return Landscape
If you would invest 664.00 in Passage Bio on November 4, 2025 and sell it today you would earn a total of 486.00 from holding Passage Bio or generate 73.19% return on investment over 90 days. Passage Bio is currently generating 1.231% in daily expected returns and assumes 8.4153% risk (volatility on return distribution) over the 90 days horizon. In different words, 75% of stocks are less volatile than Passage, and 76% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Passage Bio Target Price Odds to finish over Current Price
The tendency of Passage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 11.50 | 90 days | 11.50 | about 37.3 |
Based on a normal probability distribution, the odds of Passage Bio to move above the current price in 90 days from now is about 37.3 (This Passage Bio probability density function shows the probability of Passage Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 5.21 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Passage Bio will likely underperform. Additionally Passage Bio has an alpha of 0.8364, implying that it can generate a 0.84 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Passage Bio Price Density |
| Price |
Predictive Modules for Passage Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Passage Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Passage Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Passage Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Passage Bio is not an exception. The market had few large corrections towards the Passage Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Passage Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Passage Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.84 | |
β | Beta against Dow Jones | 5.21 | |
σ | Overall volatility | 3.18 | |
Ir | Information ratio | 0.12 |
Passage Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Passage Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Passage Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Passage Bio is way too risky over 90 days horizon | |
| Passage Bio appears to be risky and price may revert if volatility continues | |
| Passage Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (64.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Passage Bio currently holds about 239.25 M in cash with (47.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39. | |
| Latest headline from news.google.com: Moving Averages What is the earnings history of Passage Bio Inc - Market Trend Review Short-Term Trading Opportunity Alerts - baoquankhu1.vn |
Passage Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Passage Stock often depends not only on the future outlook of the current and potential Passage Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Passage Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3 M | |
| Cash And Short Term Investments | 76.8 M |
Passage Bio Fundamentals Growth
Passage Stock prices reflect investors' perceptions of the future prospects and financial health of Passage Bio, and Passage Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Passage Stock performance.
| Return On Equity | -0.87 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 5.67 M | ||||
| Shares Outstanding | 3.18 M | ||||
| Price To Book | 1.17 X | ||||
| EBITDA | (62.09 M) | ||||
| Net Income | (64.77 M) | ||||
| Cash And Equivalents | 239.25 M | ||||
| Cash Per Share | 4.39 X | ||||
| Total Debt | 25.48 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 9.23 X | ||||
| Book Value Per Share | 9.79 X | ||||
| Cash Flow From Operations | (47.96 M) | ||||
| Earnings Per Share | (14.62) X | ||||
| Market Capitalization | 36.56 M | ||||
| Total Asset | 102.41 M | ||||
| Retained Earnings | (659.24 M) | ||||
| Working Capital | 59.45 M | ||||
| Current Asset | 144.91 M | ||||
| Current Liabilities | 3.09 M | ||||
About Passage Bio Performance
By analyzing Passage Bio's fundamental ratios, stakeholders can gain valuable insights into Passage Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Passage Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Passage Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.73) | (0.76) | |
| Return On Capital Employed | (0.97) | (1.02) | |
| Return On Assets | (0.73) | (0.76) | |
| Return On Equity | (1.22) | (1.16) |
Things to note about Passage Bio performance evaluation
Checking the ongoing alerts about Passage Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Passage Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Passage Bio is way too risky over 90 days horizon | |
| Passage Bio appears to be risky and price may revert if volatility continues | |
| Passage Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (64.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Passage Bio currently holds about 239.25 M in cash with (47.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39. | |
| Latest headline from news.google.com: Moving Averages What is the earnings history of Passage Bio Inc - Market Trend Review Short-Term Trading Opportunity Alerts - baoquankhu1.vn |
- Analyzing Passage Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Passage Bio's stock is overvalued or undervalued compared to its peers.
- Examining Passage Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Passage Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Passage Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Passage Bio's stock. These opinions can provide insight into Passage Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Passage Stock analysis
When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |